Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets

Neurotoxicology and Teratology

Volumn 33, Issue 6, 2011, Pages 608-617

  Rico, E P ^a,b   Rosemberg, D B ^a,b   Seibt, K J ^c,d   Capiotti, K M ^c,d   Da Silva, R S ^c,d   Bonan, C D ^c,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (INCT EN)   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina INCT TM   (Brazil)

Author keywords

Contaminants; Neurotoxicity; Neurotransmission; Zebrafish

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADENOSINE; ALCOHOL; CHLORPYRIFOS; CLOZAPINE; COPPER; DOPAMINE; DOPAMINE RECEPTOR; FIPRONIL; FLUPHENAZINE; GLUTAMIC ACID; GLYCINE; HALOPERIDOL; HISTAMINE; LEVODOPA; LYSERGIDE; MERCURY; METHANOL; NEUROTRANSMITTER; NICOTINE; NITRIC OXIDE; OXIDOPAMINE; PENTETRAZOLE; PURINE NUCLEOSIDE; PURINE NUCLEOTIDE; SEROTONIN; SILVER; UNINDEXED DRUG;

ARTICLE; BRAIN NERVE CELL; DRUG MECHANISM; EXPERIMENTAL ANIMAL; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPHARMACOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; ZEBRA FISH;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; MODELS, ANIMAL; NEUROTRANSMITTER AGENTS; PHARMACOLOGY; SYNAPTIC TRANSMISSION; TOXICOLOGY; ZEBRAFISH;

ANIMALIA; DANIO RERIO;

EID: 84855943743     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.07.007     Document Type: Article

References (164)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006, 58(3):281-341.
2. Agresti C., Meomartini M.E., Amadio S., Ambrosini E., Serafini B., Franchini L., et al. Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development. Glia 2005, 50(2):132-144.
3. Airhart M.J., Lee D.H., Wilson T.D., Miller B.E., Miller M.N., Skalko R.G. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). Neurotoxicol Teratol 2007, 29(6):652-664.
4. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001, 357:593-615.
5. Alkondon M., Rocha E.S., Maelicke A., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J Pharmacol Exp Ther 1996, 278(3):1460-1471.
6. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
7. Anichtchik O.V., Rinne J.O., Kalimo H., Panula P. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 2000, 163(1):20-30.
8. Anichtchik O.V., Kaslin J., Peitsaro N., Scheinin M., Panula P. Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 2004, 88(2):443-453.
9. Appelbaum L., Skariah G., Mourrain P., Mignot E. Comparative expression of p2x receptors and ecto-nucleoside triphosphate diphosphohydrolase 3 in hypocretin and sensory neurons in zebrafish. Brain Res 2007, 1174:66-75.
10. Arenzana F.J., Clemente D., Sánchez-González R., Porteros A., Aijón J., Arévalo R. Development of the cholinergic system in the brain and retina of the zebrafish. Brain Res Bull 2005, 66(4-6):421-425.
11. Baraban S.C., Taylor M.R., Castro P.A., Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 2005, 131(3):759-768.
12. Barbazuk W.B., Korf I., Kadavi C., Heyen J., Tate S., Wun E., et al. The syntenic relationship of the zebrafish and human genomes. Genome Res 2000, 10:1351-1358.
13. Belmaker R.H. The future of depression psychopharmacology. CNS Spectr 2008, 13:682-687.
14. Bencan Z., Levin E.D. The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish. Physiol Behav 2008, 95(3):408-412.
15. Berghmans S., Hunt J., Roach A., Goldsmith P. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res 2007, 75(1):18-28.
16. Blank M., Guerim L.D., Cordeiro R.F., Vianna M.R. A one-trial inhibitory avoidance task to zebrafish: rapid acquisition of an NMDA-dependent long-term memory. Neurobiol Learn Mem 2009, 92(4):529-534.
17. Boehmler W., Carr T., Thisse C., Thisse B., Canfield V., Levenson R. D4 dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour. Genes Brain Behav 2007, 6:155-166.
18. Boehmler W., Petko J., Woll M., Frey C., Thisse B., Thisse C., et al. Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr Patterns 2009, 9(3):144-151.
19. Bonan C.D., Schetinger M.R.C., Battastini A.M.O., Sarkis J.J.F. Ectonucleotidases and synaptic plasticity: implications in physiological and pathological conditions. Drug Dev Res 2001, 52:57-65.
20. Boué-Grabot E., Akimenko M.A., Séguéla P. Unique functional properties of a sensory neuronal P2X ATP-gated channel from zebrafish. J Neurochem 2000, 75(4):1600-1607.
21. Bowman T.V., Zon L.I. Swimming into the future of drug discovery: in vivo chemical screens in zebrafish. ACS Chem Biol 2010, 5(2):159-161.
22. Brewer G.J. Neuronal plasticity and stressor toxicity during aging. Exp Gerontol 2000, 35(9-10):1165-1183.
23. Brown D.A. Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms. J Mol Neurosci 2010, 41(3):340-346.
24. Burnstock G. Do some sympathetic neurones synthesize and release both noradrenaline and acetylcholine?. Prog Neurobiol 1978, 11(3-4):205-222.
25. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor?. Gen Pharmacol 1985, 16:433-440.
26. Callier S., Snapyan M., Le Crom S., Prou D., Vincent J.D., Vernier P. Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell 2003, 95(7):489-502.
27. Chatterjee D., Gerlai R. High precision liquid chromatography analysis of dopaminergic and serotoninergic responses to acute alcohol exposure in zebrafish. Behav Brain Res 2009, 200(1):208-213.
28. Chen Y., Swnason R.A. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003, 23:137-149.
29. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1(8):623-634.
30. Clemente D., Porteros A., Weruaga E., Alonso J.R., Arenzana F.J., Aijón J., et al. Cholinergic elements in the zebrafish central nervous system: Histochemical and immunohistochemical analysis. J Comp Neurol 2004, 474(1):75-107.
31. Connaughton V.P., Behar T.N., Liu W.L.S., Massey S.C. Immunocytochemical localization of excitatory and inhibitory neurotransmitters in the zebrafish retina. Vis Neurosci 1999, 16:483-490.
32. Cote F., Fligny C., Bayard E., Launay J.M., Gershon M.D., Mallet J., et al. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci U S A 2007, 104:329-334.
33. Cox J.A., Kucenas S., Voigt M.M. Molecular characterization and embryonic expression of the family of N-methyl-D-aspartate receptor subunit genes in the zebrafish. J Dev Dyn 2005, 234(3):756-766.
34. Cramer K.S., Leamey C.A., Sur M. Nitric oxide as a signalling molecule in visual system development. Progress Brain Res. 1998, 101-114. Elsevier, Amsterdam. R.R. Mize, T.M. Dawson, V.L. Dawson, M.J. Friedlander (Eds.).
35. Danbolt N.C. Glutamate uptake. Prog Neurobiol 2001, 65:1-105.
36. Daubert E.A., Condron B.G. Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci 2010, 33:424-434.
37. Delgado L., Schmachtenberg O. Immunohistochemical localization of GABA, GAD65, and the receptor subunits GABAAalpha1 and GABAB1 in the zebrafish cerebellum. Cerebellum 2008, 7(3):444-450.
38. Demas J., Cline H.T. The blu Blur: mutation of a vesicular glutamate transporter reduces the resolution of zebrafish vision. Neuron 2007, 53(1):4-6.
39. Diaz-Hernandez M., Cox J.A., Migita K., Haines W., Egan T.M., Voigt M.M. Cloning and characterization of two novel zebrafish P2X receptor subunits. Biochem Biophys Res Commun 2002, 295(4):849-853.
40. Durand M., Coronas V., Jourdan F., Quirion R. Developmental and aging aspects of the cholinergic innervation of the olfactory bulb. Int J Dev Neurosci 1998, 16(7-8):777-785.
41. Eddins D., Cerutti D., Williams P., Linney E., Levin E.D. Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicol Teratol 2010, 32(1):99-108.
42. Edwards J.G., Michel W.C. Pharmacological characterization of ionotropic glutamate receptors in the zebrafish olfactory bulb. Neuroscience 2003, 122(4):1037-1047.
43. Egan T.M., Cox J.A., Voigt M.M. Molecular cloning and functional characterization of the zebrafish ATP-gated ionotropic receptor P2X(3) subunit. FEBS Lett 2000, 475(3):287-290.
44. Enjyoji K., Sévigny J., Lin Y., Frenette P.S., Christie P.D., Esch J.S., et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999, 5(9):1010-1017.
45. Eriksson K.S., Peitsaro N., Karlstedt K., Kaslin J., Panula P. Development of histidine decarboxylase mRNA in the zebrafish brain in the absence of all peripheral histaminergic system. Eur J Neurosci 1998, 10:3799-3812.
46. Flinn L., Bretaud S., Lo C., Ingham P.W., Bandmann O. Zebrafish as a new animal model for movement disorders. Neurochemistry 2008, 106:1991-1997.
47. Fricker A.D., Rios C., Devi L.A., Gomes I. Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Brain Res Mol Brain Res 2005, 138:228-235.
48. Fritsche R., Schwerte T., Peitser B. Nitric oxide and vascular reactivity in development zebrafish, Danio rerio. Am J Physiol Regul Integr Comp Physiol 2000, 279:2200-2207.
49. Fucile S., Saint Jan D., David-Watine B., Korn H., Bregestovski P. Comparison of glycine and GABA actions on the zebrafish homomeric glycine receptor. J Physiol 1999, 517(2):369-383.
50. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003, 4:1002-1012.
51. Gerlai R., Lahav M., Guo S., Rosenthal A. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 2000, 67:773-782.
52. Gerlai R., Ahmad F., Prajapati S. Differences in acute alcohol-induced behavioral responses among zebrafish populations. Alcohol Clin Exp Res 2008, 32:1763-1773.
53. Gerlai R., Chatterjee D., Pereira T., Sawashima T., Krishnannair R. Acute and chronic alcohol dose: population differences in behavior and neurochemistry of zebrafish. Genes Brain Behav 2009, 8(6):586-599.
54. Gesemann M., Lesslauer A., Maurer C.M., Schönthaler H.B., Neuhauss S.C. Phylogenetic analysis of the vertebrate excitatory/neutral amino acid transporter (SLC1/EAAT) family reveals lineage specific subfamilies. BMC Evol Biol 2010, 10:117.
55. Giacomini N.J., Rose B., Kobayashi K., Guo S. Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicol Teratol 2006, 28:245-250.
56. Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv Pharmacol 1998, 42:707-711.
57. Gregory M., Jagadeeswaran P. Selective labeling of zebrafish thrombocytes: quantitation of thrombocyte function and detection during development. Blood Cells Mol Dis 2002, 28(3):418-427.
58. Grillner S., Deliagina T., Ekeberg O., el Manira A., Hill R.H., Lansner A., et al. Neural networks that coordinate locomotion and body orientation in lamprey. Trends Neurosci 1995, 18:270-279.
59. Grossman L., Utterback E., Stewart A., Gaikwad S., Wong K., Elegante M., et al. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 2010, 214:277-284.
60. Haas H., Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 2003, 4(2):121-130.
61. Hanneman E., Westerfield M. Early expression of acetylcholinesterase activity in functionally distinct neurons of the zebrafish. J Comp Neurol 1989, 284(3):350-361.
62. Hill A.J., Teraoka H., Heideman W., Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005, 86(1):6-19.
63. Hirata H., Carta E., Yamanaka I., Harvey R.J., Kuwada J.Y. Defective glycinergic synaptic transmission in zebrafish motility mutants. Front Mol Neurosci 2010, 2:26.
64. Holmqvist B., Ellingsen B., Alm P., Forsell J., Oyan M.A., Goksøyr A., et al. Identification and distribution of nitric oxide synthase in the brain the zebrafish. Neurosci Lett 2000, 292:119-122.
65. Hortopan G.A., Dinday M.T., Baraban S.C. Spontaneous seizures and altered gene expression in GABA signaling pathways in a mind bomb mutant zebrafish. J Neurosci 2010, 30(41):13718-13728.
66. Hultborn H., Nielsen J.B. Spinal control of locomotion from cat to man. Acta Physiol (Oxf) 2007, 189:111-121.
67. Ikonomidou C., Price M.T., Mosinger J.L., Frierdich G., Labruyere J., Salles K.S., et al. Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain. J Neurosci 1989, 9(5):1693-1700.
68. Ingram E.M., Wiseman J.W., Tessler S., Emson P.C. Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse. J Neurochem 2001, 79(3):564-575.
69. Ivetac I., Becanovic J., Krishnapillai V. Zebrafish: genetic tools and genomics, Asia-Pacific. J Mol Biol Biotechnol 2000, 8:1-11.
70. Izquierdo I., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampuss and its connection to activity in other brain structures. Neurobiol Learn Mem 1997, 68:285-316.
71. Jamal M., Ameno K., Miki T., Wang W., Kumihashi M., Isse T., et al. Cholinergic alterations following alcohol exposure in the frontal cortex of Aldh2-deficient mice models. Brain Res 2009, 1295:37-43.
72. Jin C.Y., Anichtchik O., Panula P. Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases. Br J Pharmacol 2009, 157(1):118-129.
73. Kaslin J., Nystedt J.M., Ostergård M., Peitsaro N., Panula P. The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems. J Neurosci 2004, 24(11):2678-2689.
74. Kenney J.W., Florian C., Portugal G.S., Abel T., Gould T.J. Involvement of hippocampal jun-N terminal kinase pathway in the enhancement of learning and memory by nicotine. Neuropsychopharmacology 2010, 35(2):483-492.
75. Khakh B.S., Burnstock G., Kennedy C., King B.F., North R.A., Séguéla P., et al. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 2001, 53(1):107-118.
76. Kim Y.J., Nam R.H., Yoo Y.M., Lee C.J. Identification and functional evidence of GABAergic neurons in parts of the brain of adult zebrafish (Danio rerio). Neurosci Lett 2004, 355(1-2):29-32.
77. Kucenas S., Li Z., Cox J.A., Egan T.M., Voigt M.M. Molecular characterization of the zebrafish P2X receptor subunit gene family. Neuroscience 2003, 121(4):935-945.
78. Kucenas S., Cox J.A., Soto F., Lamora A., Voigt M.M. Ectodermal P2X receptor function plays a pivotal role in craniofacial development of the zebrafish. Purinergic Signal 2009, 5(3):395-407.
79. Legendre P. Pharmacological evidence for two types of postsynaptic glycinergic receptors on the Mauthner cell of 52-h-old zebrafish larvae. J Neurophysiol 1997, 77:2400-2415.
80. Legendre P. A reluctant gating mode of glycine receptor channels determines the time course of inhibitory miniature synaptic events in zebrafish hindbrain neurons. J Neurosci 1998, 18(8):2856-2870.
81. Lele Z., Krone P.H. The zebrafish as a model system in developmental, toxicological and transgenic research. Biotechnol Adv 1996, 14(1):57-72.
82. Levin E.D., Chen E. Nicotinic involvement in memory function in zebrafish. Neurotoxicol Teratol 2004, 26(6):731-735.
83. Levin E.D., Bencan Z., Cerutti D.T. Anxiolytic effects of nicotine in zebrafish. Physiol Behav 2007, 90(1):54-58.
84. Lipinski J.F., Schaumburg H.H., Baldessarini R.J. Regional distribution of histamine in human brain. Brain Res 1973, 52:403-408.
85. Liu C., Wilson S.J., Kuei C., Lovenberg T.W. Comparison of human, mouse, rat and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 2001, 299:121-130.
86. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998, 44:151-162.
87. Maragakis N.J., Rothstein J.D. Glutamate transporters in neurologic disease. Arch Neurol 2001, 58(3):365-370.
88. Maragakis N.J., Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 2004, 15:461-473.
89. Mattson M.P., Chan S.L., Duan W. Modification of brain ageing and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 2002, 82:637-672.
90. McDearmid J.R., Liao M., Drapeau P. Glycine receptors regulate interneuron differentiation during spinal network development. Proc Natl Acad Sci U S A 2006, 103(25):9679-9684.
91. Meek J. Tectal morphology: connections, neurons and synapses. The visual system of Fish 1990, 239-277. Chapman and Hall, London. R.H. Douglas, M.B.A. Djamgoz (Eds.).
92. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 1998, 78:189-225.
93. Mochizuki T., Yamatodani A., Okakura K., Horii A., Inagaki N., Wada H. Circadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol Behav 1992, 51(2):391-394.
94. Moncada S., Nistico G., Bagetta G., Higgs E. Nitric oxide and the cell proliferation, differentiation and death 1998, 320. Portland Press, United Kingdon.
95. Mongeon R., Gleason M.R., Masino M.A., Fetcho J.R., Mandel G., Brehm P., et al. Synaptic homeostasis in a zebrafish glial glycine transporter mutant. J Neurophysiol 2008, 100:1716-1723.
96. Mueller T., Vernier P., Wullimann M.F. The adult central nervous cholinergic system of a neurogenetic model animal, the zebrafish Danio rerio. Brain Res 2004, 1011(2):156-169.
97. Murray R.M., Lappin J., Di Forti M. Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol 2008, (Suppl 3):S129-S134.
98. Nakanishi S., Masu M., Bessho Y., Nakajima Y., Hayashi Y., Shigemoto R. Molecular diversity of glutamate receptors and their physiological functions. Experientia Suppl 1994, 71:71-80.
99. Nam R.H., Kim W., Lee C.J. NMDA receptor-dependent long-term potentiation in the telencephalon of the zebrafish. Neurosci Lett 2004, 370(2-3):248-251.
100. Neuhauss S.C., Rico E.P., Gesemann M. Nomenclature of glutamate transporters in zebrafish and other vertebrates. Brain Res Bull 2010, 83(6):297.
101. Northcutt R.G. Evolution of the optic tectum in ray-finned fishes. Fish neurobiology 2: higher brain areas and functions 1981, 1-42. University of Michigan Press, Ann. Arbor. R.E. Davis, R.G. Northcutt (Eds.).
102. Norton W.H., Rohr K.B., Burnstock G. Embryonic expression of a P2X(3) receptor encoding gene in zebrafish. Mech Dev 2000, 99(1-2):149-152.
103. Nürnberger A., Räbiger M., Mack A., Diaz J., Sokoloff P., Mühlbauer B., et al. Subapical localization of the dopamine D3 receptor in proximal tubules of them rat kidney. J Histochem Cytochem 2004, 52(12):1647-1655.
104. Obholzer N., Wolfson S., Trapani J.G., Mo W., Nechiporuk A., Busch-Nentwich E., et al. Vesicular glutamate transporter 3 is required for synaptic transmission in zebrafish hair cells. J Neurosci 2008, 28(9):2110-2118.
105. Ozawa A., Kamiya H., Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998, 54:581-618.
106. Panula P., Yang HY T., Costa E. Histamine-containing neurons in rat hypothalamus. Proc Natl Acad Sci U S A 1984, 81:2572-2576.
107. Panula P., Rinne J., Kuokkanen K., Eriksson K.S., Sallmen T., Kalimo H., et al. Neuronal histamine deficit in Alzheimer's disease. Neuroscience 1998, 82(4):993-997.
108. Panula P., Sallinen V., Sundvik M., Kolehmainen J., Torkko V., Tiittula A., et al. Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 2006, 3(2):235-247.
109. Panula P., Chen Y.C., Priyadarshini M., Kudo H., Semenova S., Sundvik M., et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 2010, 40(1):46-57.
110. Parng C., Roy N.M., Ton C., Lin Y., McGrath P. Neurotoxicity assessment using zebrafish. J Pharmacol Toxicol Methods 2007, 55(1):103-112.
111. Parsey R.V. Serotonin receptor imaging: clinically useful?. J Nucl Med 2010, 51(10):1495-1498.
112. Paterniti I., Melani A., Cipriani S., Corti F., Mello T., Mazzon E., et al. Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. J Neuroinflammation 2011, 8(1):31.
113. Peitsaro N., Anichtchik O.V., Panula P. Identification of a histamine H(3)-like receptor in the zebrafish (Danio rerio) brain. J Neurochem 2000, 75:718-724.
114. Peitsaro N., Kaslin J., Anitchick O.V., Panula P. Modulation of histaminergic system and behaviour by alpha-fluorothylhistidine in zebrafish. J Neurochem 2003, 86:432-441.
115. Peitsaro N., Sundvik M., Anichtchik O.V., Kaslin J., Panula P. Identification of zebrafish histamine H1, H2 and H3 receptors and effects of histaminergic ligands on behavior. Biochem Pharmacol 2007, 73(8):1205-1214.
116. Pool K.L., Richardson M., Lan S.C., Khoo H.E., Korzh V. Expression pattern of neuronal nitric oxide synthase in embryonic zebrafish. Gene Expr Patterns 2007, 3(4):463-466.
117. Portavella M., Vargas J.P., Torres B., Salas C. The effects of telencephalic pallial lesions on spatial, temporal, and emotional learning in goldfish. Brain Res Bull 2002, 57(3-4):397-399.
118. Powers C.M., Levin E.D., Seidler F.J., Slotkin T.A. Silver exposure in developing zebrafish produces persistent synaptic and behavioral changes. Neurotoxicol Teratol 2011, 33(2):329-332.
119. Prange O., Wong T.P., Gerrow K., Wang Y.T., El-Husseini A. A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc Natl Acad Sci U S A 2004, 101(38):13915-13920.
120. Raiteri M. Functional pharmacology in human brain. Pharmacol Rev 2006, 58(2):162-193.
121. Renier C., Faraco J.H., Bourgin P., Motley T., Bonaventure P., Rosa F., et al. Genomic and functional conservation of sedative-hypnotic targets in the zebrafish. Pharmacogenet Genomics 2007, 17(4):237-253.
122. Ricatti M.J., Alfie L.D., Lavoie E.G., Sévigny J., Schwarzbaum P.J., Faillace M.P. Immunocytochemical localization of NTPDases1 and 2 in the neural retina of mouse and zebrafish. Synapse 2009, 63(4):291-307.
123. Richetti S.K., Rosemberg D.B., Ventura-Lima J., Monserrat J.M., Bogo M.R., Bonan C.D. Acetylcholinesterase activity and antioxidant capacity of zebrafish brain is altered by heavy metal exposure. Neurotoxicology 2011, 32(1):116-122.
124. Rico E.P., Senger M.R., Fauth M.da G., Dias R.D., Bogo M.R., Bonan C.D. ATP and ADP hydrolysis in brain membranes of zebrafish (Danio rerio). Life Sci 2003, 73(16):2071-2082.
125. Rico E.P., Rosemberg D.B., Senger M.R., Arizi M.de B., Bernardi G.F., Dias R.D., et al. Methanol alters ecto-nucleotidases and acetylcholinesterase in zebrafish brain. Neurotoxicol Teratol 2006, 28(4):489-496.
126. Rico E.P., Rosemberg D.B., Dias R.D., Bogo M.R., Bonan C.D. Ethanol alters acetylcholinesterase activity and gene expression in zebrafish brain. Toxicol Lett 2007, 174(1-3):25-30.
127. Rico E.P., Rosemberg D.B., Senger M.R., de Bem Arizi M., Dias R.D., Souto A.A., et al. Ethanol and acetaldehyde alter NTPDase and 5'-nucleotidase fromzebrafish brain membranes. Neurochem Int 2008, 52(1-2):290-296.
128. Rico E.P., de Oliveira D.L., Rosemberg D.B., Mussulini B.H., Bonan C.D., Dias R.D., et al. Expression and functional analysis of Na(+)-dependent glutamate transporters from zebrafish brain. Brain Res Bull 2010, 81(4-5):517-523.
129. Robson S., Sévigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2006, 2:409-430.
130. Rodd-Henricks Z.A., McKinzie D.L., Edmundson V.E., Dagon C.L., Murphy J.M., McBride W.J., et al. Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats. Alcohol 2000, 21(1):73-85.
131. Rodríguez F., López J.C., Vargas J.P., Broglio C., Gómez Y., Salas C. Spatial memory and hippocampal pallium through vertebrate evolution: insights from reptiles and teleost fish. Brain Res Bull 2002, 57(3-4):499-503.
132. Rosemberg D.B., Rico E.P., Guidoti M.R., Dias R.D., Souza D.O., Bonan C.D., et al. Adenosine deaminase-related genes: molecular identification, tissue expression pattern and truncated alternative splice isoform in adult zebrafish (Danio rerio). Life Sci 2007, 81(21-22):1526-1534.
133. Rosemberg D.B., Rico E.P., Senger M.R., Arizi M.de B., Dias R.D., Bogo M.R., et al. Acute and subchronic copper treatments alter extracellular nucleotide hydrolysis in zebrafish brain membranes. Toxicology 2007, 236(1-2):132-139.
134. Rosemberg D.B., Rico E.P., Senger M.R., Dias R.D., Bogo M.R., Bonan C.D., et al. Kinetic characterization of adenosine deaminase activity in zebrafish (Danio rerio) brain. Comp Biochem Physiol B Biochem Mol Biol 2008, 151(1):96-101.
135. Rosemberg D.B., da Rocha R.F., Rico E.P., Zanotto-Filho A., Dias R.D., Bogo M.R., et al. Taurine prevents enhancement of acetylcholinesterase activity induced by acute ethanol exposure and decreases the level of markers of oxidative stress in zebrafish brain. Neuroscience 2010, 171(3):683-692.
136. Rosemberg D.B., Rico E.P., Langoni A.S., Spinelli J.T., Pereira T.C., Dias R.D., et al. NTPDase family in zebrafish: nucleotide hydrolysis, molecular identification and gene expression profiles in brain, liver and heart. Comp Biochem Physiol B Biochem Mol Biol 2010, 155(3):230-240.
137. Rosemberg D.B., Rico E.P., Mussulini B.H., Piato A.L., Calcagnotto M.E., Bonan C.D., et al. Differences in the spatio-temporal behavior of zebrafish in the open tank paradigm after a short-period confinement into dark and bright environments. PLoS One 2011, 6(5):e19397.
138. Saint-Amant L., Drapeau P. Motoneuron activity patterns related to the earliest behavior of the zebrafish embryo. J Neurosci 2000, 20:3964-3972.
139. Sallinen V., Sundvik M., Renila I., Peitsaro N., Khrustalyov D., Anichtchik O., et al. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 2009, 109(2):403-415.
140. Schetinger M.R., Morsch V.M., Bonan C.D., Wyse A.T. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors 2007, 31(2):77-98.
141. Schultz W. Getting formal with dopamine and reward. Neuron 2002, 36:241-263.
142. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in mammalian brain. Physiol Rev 1991, 71:1-51.
143. Segovia G., Porras A., Del Arco A., Mora F. Glutamatergic neurotransmission in aging: a critical perspective. Mech Ageing Dev 2001, 122(1):1-29.
144. Seibt K.J., Oliveira R.da L., Rico E.P., Dias R.D., Bogo M.R., Bonan C.D. Typical and atypical antipsychotics alter acetylcholinesterase activity and AChE expression in zebrafish (Danio rerio) brain. Comp Biochem Physiol C Toxicol Pharmacol 2009, 150(1):10-15.
145. Senger M.R., Rico E.P., Dias R.D., Bogo M.R., Bonan C.D. Ecto-5'-nucleotidase activity in brain membranes of zebrafish (Danio rerio). Comp Biochem Physiol B Biochem Mol Biol 2004, 139(2):203-207.
146. Senger M.R., Rico E.P., de Bem Arizi M., Rosemberg D.B., Dias R.D., Bogo M.R., et al. Carbofuran and malathion inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes. Toxicology 2005, 212(2-3):107-115.
147. Senger M.R., Rico E.P., de Bem Arizi M., Frazzon A.P., Dias R.D., Bogo M.R., et al. Exposure to Hg2+ and Pb2+ changes NTPDase and ecto-5'-nucleotidase activities in central nervous system of zebrafish (Danio rerio). Toxicology 2006, 226(2-3):229-237.
148. Senger M.R., Rosemberg D.B., Rico E.P., de Bem Arizi M., Dias R.D., Bogo M.R., et al. In vitro effect of zinc and cadmium on acetylcholinesterase and ectonucleotidase activities in zebrafish (Danio rerio) brain. Toxicol In Vitro 2006, 20(6):954-958.
149. Senger M.R., Rosemberg D.B., Seibt K.J., Dias R.D., Bogo M.R., Bonan C.D. Influence of mercury chloride on adenosine deaminase activity and gene expression in zebrafish (Danio rerio) brain. Neurotoxicology 2010, 31(3):291-296.
150. Siebel A.M., Rico E.P., Capiotti K.M., Piato A.L., Cusinato C.T., Franco T.M., et al. In vitro effects of antiepileptic drugs on acetylcholinesterase and ectonucleotidase activities in zebrafish (Danio rerio) brain. Toxicol In Vitro 2010, 24(4):1279-1284.
151. Smear M.C., Tao H.W., Staub W., Orger M.B., Gosse N.J., Liu Y., et al. Vesicular glutamate transport at a central synapse limits the acuity of visual perception in zebrafish. Neuron 2007, 53(1):65-77.
152. Steele S.L., Lo K.H., Li V.W., Cheng S.H., Ekker M., Perry S.F. Loss of M2 muscarinic receptor function inhibits development of hypoxic bradycardia and alters cardiac beta-adrenergic sensitivity in larval zebrafish (Danio rerio). Am J Physiol Regul Integr Comp Physiol 2009, 297(2):R412-R420.
153. Sukardi H., Ung C.Y., Gong Z., Lam S.H. Incorporating zebrafish omics into chemical biology and toxicology. Zebrafish 2010, 7(1):41-52.
154. Surmeier D.J., Ding J., Day M., Wang Z., Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007, 30(5):228-235.
155. Tabor R., Friedrich R.W. Pharmacological analysis of ionotropic glutamate receptor function in neuronal circuits of the zebrafish olfactory bulb. PLoS One 2008, 3(1):e1416.
156. Thielen R.J., Engleman E.A., Rodd Z.A., Murphy J.M., Lumeng L., Li T.K., et al. Ethanol drinking and deprivation alter dopaminergic and serotonergic function in the nucleus accumbens of alcohol-preferring rats. J Pharmacol Exp Ther 2004, 309(1):216-225.
157. Todd K.J., Slatter C.A., Ali D.W. Activation of ionotropic glutamate receptors on peripheral axons of primary motoneurons mediates transmitter release at the zebrafish NMJ. J Neurophysiol 2004, 91(2):828-840.
158. Van Dycke A., Raedt R., Dauwe I., Sante T., Wyckhuys T., Meurs A., et al. Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures. Epilepsia 2010, 51(9):1721-1728.
159. Vascotto S.G., Beckham Y., Kelly G.M. The zebrafish's swim to fame as an experimental model in biology. Biochem Cell Biol 1997, 75:479-485.
160. Vizi E.S., Lendvai B. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res Brain Res Rev 1999, 30(3):219-235.
161. Williams F.E., Messer W.S. Muscarinic acetylcholine receptors in the brain of the zebrafish (Danio rerio) measured by radioligand binding techniques. Comp Biochem Physiol C Toxicol Pharmacol 2004, 137(4):349-353.
162. Yamatodani A., Inagaki N., Panula P., Itowi N., Watanabe T., Wada H. Structure and functions of the histaminergic neuron system. Histamine and histamine agonists 1991, 243-283. Springer, Heidelberg.
163. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008, 1783(5):673-694.
164. Zimmermann H. Ectonucleotidases: some developments and a note on nomenclature. Drug Dev Res 2001, 52:44-56.